Literature DB >> 7667269

Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.

M E Bromberg1, W H Konigsberg, J F Madison, A Pawashe, A Garen.   

Abstract

Several studies have established a link between blood coagulation and cancer, and more specifically between tissue factor (TF), a transmembrane protein involved in initiating blood coagulation, and tumor metastasis. In the study reported here, a murine model of human melanoma metastasis was used for two experiments. (i) The first experiment was designed to test the effect of varying the level of TF expression in human melanoma cells on their metastatic potential. Two matched sets of cloned human melanoma lines, one expressing a high level and the other a low level of the normal human TF molecule, were generated by retroviral-mediated transfections of a nonmetastatic parental line. The metastatic potential of the two sets of transfected lines was compared by injecting the tumor cells into the tail vein of severe combined immunodeficiency (SCID) mice and later examining the lungs and other tissues for tumor development. Metastatic tumors were detected in 86% of the mice injected with the high-TF lines and in 5% of the mice injected with the low-TF lines, indicating that a high TF level promotes metastasis of human melanoma in the SCID mouse model. This TF effect on metastasis occurs with i.v.-injected melanoma cells but does not occur with primary tumors formed from s.c.-injected melanoma cells, suggesting that TF acts at a late stage of metastasis, after tumor cells have escaped from the primary site and entered the blood. (ii) The second experiment was designed to analyze the mechanism by which TF promotes melanoma metastasis. The procedure involved testing the effect on metastasis of mutations in either the extracellular or cytoplasmic domains of the transmembrane TF molecule. The extracellular mutations introduced two amino acid substitutions that inhibited initiation by TF of the blood-coagulation cascade; the cytoplasmic mutation deleted most of the cytoplasmic domain without impairing the coagulation function of TF. Several human melanoma lines expressing high levels of either of the two mutant TF molecules were generated by retroviral-mediated transfection of the corresponding TF cDNA into the nonmetastatic parental melanoma line, and the metastatic potential of each transfected line was tested in the SCID mouse model. Metastases occurred in most mice injected with the melanoma lines expressing the extracellular TF mutant but were not detected in most mice injected with the melanoma lines expressing the cytoplasmic TF mutant. Results with the extracellular TF mutant indicate that the metastatic effect of TF in the SCID mouse model does not involve products of the coagulation cascade. Results with the cytoplasmic TF mutant indicate that the cytoplasmic domain of TF is important for the metastatic effect, suggesting that the TF could transduce a melanoma cell signal that promotes metastasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667269      PMCID: PMC41125          DOI: 10.1073/pnas.92.18.8205

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

Review 2.  The structural biology of expression and function of tissue factor.

Authors:  T S Edgington; N Mackman; K Brand; W Ruf
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

Review 3.  Tissue factor and hemostasis.

Authors:  Y Nemerson
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

4.  Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine.

Authors:  R Bach; R Gentry; Y Nemerson
Journal:  Biochemistry       Date:  1986-07-15       Impact factor: 3.162

5.  Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.

Authors:  E K Spicer; R Horton; L Bloem; R Bach; K R Williams; A Guha; J Kraus; T C Lin; Y Nemerson; W H Konigsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Authors:  D T Connolly; D M Heuvelman; R Nelson; J V Olander; B L Eppley; J J Delfino; N R Siegel; R M Leimgruber; J Feder
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

7.  Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor.

Authors:  J A Røttingen; T Enden; E Camerer; J G Iversen; H Prydz
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

8.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.

Authors:  G H Sack; J Levin; W R Bell
Journal:  Medicine (Baltimore)       Date:  1977-01       Impact factor: 1.889

9.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.

Authors:  J M McCune; R Namikawa; H Kaneshima; L D Shultz; M Lieberman; I L Weissman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

Review 10.  Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis.

Authors:  I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

View more
  65 in total

1.  Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.

Authors:  T H Bugge; Q Xiao; K W Kombrinck; M J Flick; K Holmbäck; M J Danton; M C Colbert; D P Witte; K Fujikawa; E W Davie; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 2.  Normal and pathological functions of mammalian retroelements.

Authors:  Albert Deisseroth
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

3.  Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.

Authors:  Zhiwei Hu; Rulong Shen; Amanda Campbell; Elizabeth McMichael; Lianbo Yu; Bhuvaneswari Ramaswamy; Cheryl A London; Tian Xu; William E Carson
Journal:  Cancer Immunol Res       Date:  2018-04-05       Impact factor: 11.151

Review 4.  Tissue factor and PAR2 signaling in the tumor microenvironment.

Authors:  Florence Schaffner; Wolfram Ruf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

5.  Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.

Authors:  E G Fischer; M Riewald; H Y Huang; Y Miyagi; Y Kubota; B M Mueller; W Ruf
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

6.  Human single-chain Fv immunoconjugates targeted to a melanoma-associated chondroitin sulfate proteoglycan mediate specific lysis of human melanoma cells by natural killer cells and complement.

Authors:  B Wang; Y B Chen; O Ayalon; J Bender; A Garen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.

Authors:  Andrea Dorfleutner; Edith Hintermann; Takehiko Tarui; Yoshikazu Takada; Wolfram Ruf
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

8.  Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor.

Authors:  Shiva Keshava; Sanghamitra Sahoo; Torry A Tucker; Steven Idell; L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

9.  Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

Authors:  Gertrud M Hjortoe; Lars C Petersen; Tatjana Albrektsen; Brit B Sorensen; Peder L Norby; Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

10.  Emerging roles of PAR-1 and PAFR in melanoma metastasis.

Authors:  Vladislava O Melnikova; Gabriel J Villares; Menashe Bar-Eli
Journal:  Cancer Microenviron       Date:  2008-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.